Advert - Bayer Healthcare
Date posted01 May 2011
For issuing an advertisement about Yasmin which underplayed the side effects of the medicine and which was misleading and inconsistent with the summary of product characteristics, Bayer Healthcare was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.
Clause 3.2 - Encouraging prescribers to consider prescribing Yasmin for reasons other than its licenced indication.
Clause 7.2 - Making misleading claims.
Clause 7.9 - Underplaying the side-effects of Yasmin.